Tag: restenosis
Peca Labs receives expanded CE mark for exGraft family of vascular...
Peca Labs has received an additional CE mark for its exGraft family of vascular grafts, expanding its on-label use.
ExGraft vascular grafts are intended...
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance's sirolimus-eluting balloon, has received conditional US Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical...
VIVA 2019: Perivascular temsirolimus could be “viable alternative” to prevent restenosis...
It was announced today that results of the TANGO low-dose cohort compared to controls are positive, both for primary and secondary endpoints. These latest...
Novel paclitaxel-nano-coated balloon achieves lower incidence of restenosis than plain balloon...
Two-year results of EffPac—a randomised controlled trial to assess the safety and efficacy of a novel drug-coated balloon (DCB) with a nanotechnology coating—have been...
Two-year trial data show “astonishing results” for luminor DCB
Ulf Teichgräber (Jena, Germany), talks to Vascular News at EuroPCR 2019 about the EFFPAC trial which compared the luminor (iVascular) drug-coated balloon (DCB) with...
Terumo gets CE mark for Kanshas drug-coated balloon catheter for lower...
Terumo has announced that it acquired CE mark for the Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease....
